Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Reali

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
CPT: Pharmacometrics & Systems Pharmacology|August 4, 2025
Transforming Pediatric Rare Disease Drug Development: Enhancing Clinical Trials and Regulatory Evidence With Virtual PatientsFianne Sips, Marco Virgolin, Giuseppe Pasculli, et al.
Communications Biology|September 2, 2021
QSPcc reduces bottlenecks in computational model simulationsDanilo Tomasoni, Alessio Paris, Stefano Giampiccolo, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 20, 2020
A Quantitative Systems Pharmacology Model of Gaucher Disease Type 1 Provides Mechanistic Insight Into the Response to Substrate Reduction Therapy With EliglustatRuth Abrams, Chanchala D Kaddi, Mengdi Tao, et al.
Neurobiology of Disease|January 15, 2026
Association between plasma glucosylsphingosine levels and dyskinesia burden in GBA1-related Parkinson's diseaseMassimo Marano, Carmela Zizzo, Francesco Cavallieri, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
CPT: Pharmacometrics & Systems Pharmacology|August 4, 2025
Transforming Pediatric Rare Disease Drug Development: Enhancing Clinical Trials and Regulatory Evidence With Virtual PatientsFianne Sips, Marco Virgolin, Giuseppe Pasculli, et al.
Communications Biology|September 2, 2021
QSPcc reduces bottlenecks in computational model simulationsDanilo Tomasoni, Alessio Paris, Stefano Giampiccolo, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 20, 2020
A Quantitative Systems Pharmacology Model of Gaucher Disease Type 1 Provides Mechanistic Insight Into the Response to Substrate Reduction Therapy With EliglustatRuth Abrams, Chanchala D Kaddi, Mengdi Tao, et al.
Neurobiology of Disease|January 15, 2026
Association between plasma glucosylsphingosine levels and dyskinesia burden in GBA1-related Parkinson's diseaseMassimo Marano, Carmela Zizzo, Francesco Cavallieri, et al.
Pageof 2